20201008, Dr. Barrio, UCSD Derm, Therapy: tacrolimus and the risk of cancer
Adjuvant ET +/- 1 year of everolimus in patients with high-risk HR-positive, HER2-negative BC
Tocilizumab (Actemra®) : Evidence-Based Health Information Related to COVID-19
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
What’s New and What’s Hot in Transplantation
What's New and What's Hot - UCSF Kidney Transplant Program Update
Investigator initiated multi-center clinical trials in Canada
Antibiotic Stewardship in Oncologic Care -- Aliyah Baluch, MD
Pharmacology - Cancer Oncology drugs Nursing RN PN Full Video (MADE EASY)
Immunosuppression in the setting of Sepsis by Dr. Sudhindran S. - THC2021
Risk Factors Associated with Post-Kidney Transplant Malignancy
Safety Monitoring of Patients on Biologics and Immunosuppressants
The most exciting REAL anti-aging drugs
Ablation for Atrial Fibrillation: Is Sooner Better Than Later?
Post Transplant Immunosuppression in Autoimmune Liver Diseases by Prof. Michael A Heneghan - THC2021
Ask the Professional: 2021 Key Topics in Adult Rheumatology
Anticoagulation Management and Difficult Cases
Optimizing outcomes in IMIDs: Focus on Co-Morbidities
The Dark Side of Ginger
The Evolving World of non biologic therapies